prof. dr hab. Joanna Mika

prof. dr hab. Joanna Mika

+48 12 6623298
pokój 226
Zakład Farmakologii Bólu

Dokonania naukowe

  • Publikacje
  • Granty

Biphalin, a Dimeric Enkephalin, Alleviates LPS-Induced Activation in Rat Primary Microglial Cultures in Opioid Receptor-Dependent and Receptor-Independent Manners

Autorzy: Katarzyna Popiolek-Barczyk, Anna Piotrowska, Wioletta Makuch, Joanna Mika

DOI: 10.1155/2017/3829472
Date: 2017-01-01

Dataset of botulinum toxin A influence on interleukins under neuropathy.

Autorzy:

DOI: 10.1016/j.dib.2016.11.023
Date: 2016-12-01

Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain.

Autorzy:

DOI: 10.1016/j.ejphar.2016.09.019
Date: 2016-11-01

Intravenous lidocaine infusions in a multidirectional model of treatment of neuropathic pain patients.

Autorzy:

DOI: 10.1016/j.pharep.2016.06.010
Date: 2016-10-01

Microglial Inhibition Influences XCL1/XCR1 Expression and Causes Analgesic Effects in a Mouse Model of Diabetic Neuropathy.

Autorzy:

DOI: 10.1097/aln.0000000000001219
Date: 2016-09-01

Maraviroc reduces neuropathic pain through polarization of microglia and astroglia - Evidence from in vivo and in vitro studies.

Autorzy:

DOI: 10.1016/j.neuropharm.2016.04.024
Date: 2016-09-01

Direct and indirect pharmacological modulation of CCL2/CCR2 pathway results in attenuation of neuropathic pain - In vivo and in vitro evidence.

Autorzy:

DOI: 10.1016/j.jneuroim.2016.04.017
Date: 2016-08-01

Characteristics, diagnosis and therapeutic strategies for IgG4-related orbital disease.

Autorzy:

DOI: 10.1016/j.pharep.2015.11.011
Date: 2016-06-01

Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic Pain.

Autorzy:

DOI: 10.1021/acs.jmedchem.5b01976
Date: 2016-04-01

Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine.

Autorzy:

DOI: 10.1016/j.mcn.2015.12.013
Date: 2016-03-01

Grant

OPUS 22 2021/43/B/NZ7/00230 Nowe strategie w farmakoterapii bólu neuropatycznego oparte na modulacji układu chemokin i jego wpływie na rozwój tolerancji opioidowej

15.07.2022 – 14.07.2026

Zobacz także